Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

These cookies are essential to the proper functioning of the website and cannot be disabled by our systems. They are usually only activated in response to actions you perform, such as configuring your privacy settings, logging in, or filling out forms.

These cookies are used to improve website functionality and personalization, such as use of videos and instant messaging services. If you disable functional cookies, some or all of these features may not work properly.

No cookies to display.

These cookies allow us to determine the number of visits and sources of traffic on our site in order to measure and improve site performance. They also help us identify which pages are the most/least visited and assess how visitors use the site. All of the information collected by these cookies is aggregated, and therefore anonymized.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Full Professor, Faculty of Medicine, Université Laval
Director, Consortium for the Early Identification of Alzheimer’s Disease – Québec (CIMA-Q)
Leader of the Neuroimagery Platform, Canadian Consortium on Neurodegeneration in Aging (CCNA)

Simon Duchesne is a Biomedical Engineer Researcher at the CERVO Research Centre of the Quebec Mental Health University Institute, and a professor in the Department of Radiology and Nuclear Medicine in the Faculty of Medicine at Université Laval. He completed his university studies at the Royal Military College in Kingston, Ont. (B.Eng., Engineering Physics), and at McGill University (M.Sc., Medical Physics; Ph.D., Biomedical Engineering). He has been in Quebec since 2007, following a post-doctorate in Medical Image Processing in Rennes, France.

Dr. Duchesne co-founded the MEDICS laboratory, dedicated to the development of predictive models for medical decision support. His main focus is on cognitive aging and the neurodegeneration associated with dementia, such as Alzheimer’s disease. The overall goal of his team is to research and develop software solutions based on neuroimaging to model the human brain and its performance, in order to aid in the diagnosis and prognosis of cognitive disorders in adulthood and the elderly.

Co-founder and member of the executive committee of the Centre intégré de Neuroimagerie et Neurostimulation de Québec (CINQ), he is the director of the Consortium for Early Identification of Alzheimer’s Disease – Quebec and leader of its neuroimaging platform, as well as the leader of the neuroimaging platform of the Canadian Consortium on Neurodegeneration in Aging. He is also a member of the scientific committee of the Quebec Bio-Imaging Network, and a member of the steering committee of the Big Data Research Center (CRDM) at Université Laval.

Areas of Interest

  • Medical imaging
  • Neuroimaging
  • Magnetic resonance imaging
  • Aging
  • Neurodegeneration and Alzheimer’s disease
  • Biomarkers
  • Predictive models
  • Decision support systems

 

Research Thrust

  • Health and Life Sciences

Research Groups

  • CERVO Research Centre
  • CIMA-Q
  • CINQ
  • Canadian Consortium on Neurodegeneration in Aging (CCNA)
  • IUSMQ
  • Quebec Bio-Imaging Network

Let’s keep in touch!

Would you like to be informed about IID news and activities? Subscribe now to our monthly newsletter.